Regulatory
Summary of FDA’s “Report on the State of Pharmaceutical Quality: Fiscal year 2021”
By Mark Land, M.S., RAC, AAHP President Introduction In August of 2022, the United States Food and Drug Administration (FDA) published its fourth annual Report on the State of Pharmaceutical…
Read MoreFTC Updates Health Claims Substantiation Guidance
By Alvin J. Lorman, AAHP Legal Counsel In December 2022, the Federal Trade Commission released a lengthy guidance document on the substantiation it expects for health claims, Health Products Compliance…
Read MoreFDA Finalizes Homeopathic Guidance
By Alissa Gould, AAHP Communications Chair Seven years after the U.S. Food and Drug Administration (FDA) held a public hearing on homeopathic product regulation and two rounds of public comments,…
Read MoreFTC Proposes Making Rules Affecting Endorsements and Testimonials
By Alvin Lorman, AAHP Counsel Calling fake and deceptive product reviews and endorsements “problematic” and its remedial authority “limited,” the Federal Trade Commission (FTC) has taken the first step toward…
Read MoreDevelopments on Capitol Hill of Interest for AAHP Members
Senate Leadership of Key Committees Overseeing FDA/FTC Will See Changes in Next Congress Leaders of Influential House Committee to Remain but Role Reversal Predicted By Pete Evich, Vice President, Van…
Read MoreFDA Warning Letters for Skin Tag and Mole Removal OTCs
By Alvin Lorman, AAHP Counsel The Food and Drug Administration (FDA) has reminded two OTC drug manufacturers that mole and skin tag removal are prescription-only indications. The agency issued Warning…
Read MoreHomeopathic Promoters to Note FTC is Revising its Guide on Endorsements and Testimonials
By Mark Land, AAHP President Of the thousands of homeopathic products in the marketplace, few are ever seen advertised on television — historically, the mass medium to blanket the large…
Read MoreYour NDC Numbers are About to Change
By Eric Foxman, AAHP Secretary FDA has published a proposal that will change the required National Drug Code (NDC) format from 10 to 12 digits. Once finalized, all NDC holders…
Read MoreHouse and Senate Advance FDA User Fee Reauthorization Bills
By Pete Evich In the month of June, both the House and Senate advanced separate pieces of legislation that reauthorize FDA’s prescription drug, medical device, biosimilars, and generic drug user…
Read MoreThe Status of Homeopathic Medicinal Products in the European Union
By European Coalition on Homeopathic & Anthroposophic Medicinal Products (ECHAMP) Homeopathic medicinal products have a strong foundation in the EU law. Specific EU legislation for homeopathic medicinal products has…
Read More